The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
One partner. Every phase. Visit booth 6A2 at CPHI Milan 2026 to streamline drug development.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Why Did Thermo Fisher Scientific Acquire Patheon?
Webinar On Demand
In August 2017, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. One year later, Thermo Fisher’s Pharma Services is delivering integrated drug development and clinical trial services to clients across the globe.
In this webinar, Thermo Fisher senior executives, Franco Negron and Leon Wyszkowski, provide an inside view of how Pharma Services is redefining outsourced biopharmaceutical services.